Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice.
Open Access
- 1 April 1998
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 101 (7) , 1439-1447
- https://doi.org/10.1172/jci1963
Abstract
Corticotropin-releasing hormone (CRH) is the primary hypothalamic releasing factor that mediates the mammalian stress response. The CRH-binding protein (CRH-BP) is secreted from corticotropes, the pituitary CRH target cells, suggesting that the CRH-BP may modulate hypothalamic-pituitary-adrenal (HPA) axis activity by preventing CRH receptor stimulation. Transgenic mice were generated that constitutively express elevated levels of CRH-BP in the anterior pituitary gland. RNA and protein analyses confirmed the elevation of pituitary CRH-BP. Basal plasma concentrations of corticosterone and adrenocorticotropin hormone (ACTH) are unchanged, and a normal pattern of increased corticosterone and ACTH was observed after restraint stress. However, CRH and vasopressin (AVP) mRNA levels in the transgenic mice are increased by 82 and 35%, respectively, to compensate for the excess CRH-BP, consistent with the idea that CRH-BP levels are important for homeostasis. The transgenic mice exhibit increased activity in standard behavioral tests, and an altered circadian pattern of food intake which may be due to transgene expression in the brain. Alterations in CRH and AVP in response to elevated pituitary CRH-BP clearly demonstrate that regulation of CRH-BP is important in the function of the HPA axis.Keywords
This publication has 27 references indexed in Scilit:
- Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice.Journal of Clinical Investigation, 1997
- Regulation of Basal Corticotropin-Releasing Hormone and Arginine Vasopressin Messenger Ribonucleic Acid Expression in the Paraventricular Nucleus: Effects of Selective Hypothalamic Deafferentations*Endocrinology, 1990
- Characterization of Corticotropin-Releasing Hormone Binding Protein in Human Plasma by Chemical Cross-Linking and its Binding during Pregnancy*Journal of Clinical Endocrinology & Metabolism, 1988
- A SPECIFIC CARRIER SUBSTANCE FOR HUMAN CORTICOTROPHIN RELEASING FACTOR IN LATE GESTATIONAL MATERNAL PLASMA WHICH COULD MASK THE ACTH-RELEASING ACTIVITYClinical Endocrinology, 1988
- Effects of lateral and medial septal lesions on various activity and reactivity measures in ratsPhysiology & Behavior, 1988
- The use of a plus-maze to measure anxiety in the mousePsychopharmacology, 1987
- Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in ratsNeuroscience Letters, 1986
- The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis*Endocrine Reviews, 1986
- IMMUNOREACTIVE CORTICOTROPIN-RELEASING FACTOR IS PRESENT IN HUMAN MATERNAL PLASMA DURING THE THIRD TRIMESTER OF PREGNANCYJournal of Clinical Endocrinology & Metabolism, 1984
- Corticotropin releasing activity of the new CRF is potentiated several times by vasopressinNature, 1982